Description
LGALS4 Polyclonal Antibody | E-AB-17982 | Gentaur UK, US & Europe Distribution
Type: Polyclonal Antibody
Synonyms: Antigen NY CO 27, Antigen NY-CO-27, Antigen NYCO27, GAL 4, Gal-4, GAL4, Galectin 4, Galectin-4, Galectin4, Homo sapiens galectin4 mRNA complete cds, L 36 lactose binding protein, L-36 lactose-binding protein, L36 lactose binding protein, L36LBP, Lactose binding lectin 4, Lactose-binding lectin 4, Lectin galactoside binding soluble 4, LEG4, LGALS4
Application: WB, IHC, ELISA
Reactivity: Human
Host: Rabbit
Isotype: IgG
Reserch Areas: Epigenetics and Nuclear Signaling, Metabolism, Signal Transduction
Background: The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The expression of this gene is restricted to small intestine, colon, and rectum, and it is underexpressed in colorectal cancer.LGALS4 (Galectin 4) is a Protein Coding gene. Diseases associated with LGALS4 include Paraneoplastic Cerebellar Degeneration and Colorectal Cancer. Among its related pathways are Cell adhesion_Cell-matrix glycoconjugates. GO annotations related to this gene include carbohydrate binding. An important paralog of this gene is LGALS9.
Concentration: 0.78 mg/mL
Storage: Store at -20°C. Avoid freeze / thaw cycles.
Immunogen: Synthetic peptide of human LGALS4
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method: Antigen affinity purification
Dilution: WB 1:500-1:2000, IHC 1:30-1:150, ELISA 1:5000-1:10000
Clone: N/A
Conjugation: Unconjugated
Molecular Weight(Calculated): 36 kDa
Molecular Weight(Observed): Refer to figures